PubMed:6419786 / 1428-1607 JSONTXT

Annnotations TAB JSON ListView MergeView

    GlyCosmos15-CL

    {"project":"GlyCosmos15-CL","denotations":[{"id":"T13","span":{"begin":116,"end":118},"obj":"Cell"}],"attributes":[{"id":"A13","pred":"cl_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/CL:0004120"}],"text":"Endogenous increase in serum TSH through goitrogen treatment and exogenous TSH administration augment prostaglandin I2 contents and depress prostaglandin E2 and F2 alpha contents."}

    GlyCosmos15-Sentences

    {"project":"GlyCosmos15-Sentences","blocks":[{"id":"T9","span":{"begin":0,"end":179},"obj":"Sentence"}],"text":"Endogenous increase in serum TSH through goitrogen treatment and exogenous TSH administration augment prostaglandin I2 contents and depress prostaglandin E2 and F2 alpha contents."}

    CL-cell

    {"project":"CL-cell","denotations":[{"id":"T13","span":{"begin":116,"end":118},"obj":"Cell"}],"attributes":[{"id":"A13","pred":"cl_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/CL:0004120"}],"text":"Endogenous increase in serum TSH through goitrogen treatment and exogenous TSH administration augment prostaglandin I2 contents and depress prostaglandin E2 and F2 alpha contents."}